Gene-Targeting of Phd2 Improves Tumor Response to Chemotherapy and Prevents Side-Toxicity

Cancer Cell- United States

doi 10.1016/j.ccr.2012.06.028

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Targeting CDC7 Improves Sensitivity to Chemotherapy of Esophageal Squamous Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2018English

652 Advanced Childhood Rhabdomyosarcoma: Toxicity and Response to Intensive Chemotherapy

Pediatric Research
Child HealthPediatricsPerinatology
1978English

Targeting PIM Kinase With PD1 Inhibition Improves Immunotherapeutic Anti-Tumor T Cell Response

Clinical Cancer Research
Cancer ResearchOncology
2019English

SORBS1 Suppresses Tumor Metastasis and Improves the Sensitivity of Cancer to Chemotherapy Drug

Oncotarget
Oncology
2016English

hTERT Promoter Induces Tumor-Specific Bax Gene Expression and Cell Killing in Syngenic Mouse Tumor Model and Prevents Systemic Toxicity

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2002English

Preparative Immunotherapy With Anti-Ox40 and Anti-Ctla4 Improves the Response to Chemotherapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2014English

In Vivo Metabolic and SHG Imaging for Monitoring of Tumor Response to Chemotherapy

Cytometry Part A
Forensic MedicinePathologyHistologyCell Biology
2018English

Liraglutide Prevents Metabolic Side-Effects and Improves Recognition and Working Memory During Antipsychotic Treatment in Rats

Journal of Psychopharmacology
MedicinePsychiatryMental HealthPharmacology
2018English

Tumor Delivery of Chemotherapy Combined With Inhibitors of Angiogenesis and Vascular Targeting Agents

Frontiers in Oncology
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy